THE BUZ ON CANNABIS STOCK




Cannabis Stock 

CANNABIS BUZZ Pure play marijuana stocks are scarce. Most companies in the marijuana industry trade over the counter (OTC), where solid information regarding operations and financials is difficult to retrieve. Exceptions extend to issues such as GW Pharmaceuticals plc (NASDAQ: GWPH), a British biopharmaceutical company that developed two cannabis-based drugs licensed for use outside the United States. Sativex is used to treat muscular contractions in multiple sclerosis patients, and Epidiolex targets epileptic seizures in children. Both drugs have entered Phase 3 clinical stage trials in the United States. GWPH has a $2 billion market cap and had returned 23% year to date (YTD) as of Aug. 15, 2016.

Political and legal obstacles remain the highest hurdles for the marijuana industry in 2016. Four states, Oregon, Washington, Alaska and Colorado, have legalized recreational marijuana, and 25 states plus the District of Columbia have approved cannabis for medicinal purposes. The plant is categorized at the federal level as a Schedule 1 drug, possessing the highest risk for psychological and physical dependence, and more curiously, having no acceptable medical use.

Cannabis Wheaton and Beleave Sign Definitive Agreement For Up To $10,000,000 In Debt Financing   VANCOUVER, BC – (October 05, 2017) – Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) (“Cannabis Wheaton”or”CW”) and Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) (OTCQX: BLEVF) (“Beleave” or the “Company”) are pleased to announce that they, along with Beleave’s
Complete Reading

Alternate Health Invited to Present at the American Medical Marijuana Physicians Association’s Annual Conference   TORONTO, Oct. 5, 2017 – Alternate Health Corp (“Alternate Health” or the “Company”) (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids
Complete Reading

ACBFF Stock: The Completion of This Technical Price Pattern Will Determine What Follows Aurora Cannabis Stock Writing about investments in this market environment has been a fruitful endeavor. The market seems to only venture in one direction, the indices continue to forge new highs, and daily advances are becoming the norm. One would assume that
Complete Reading

Emblem To Disrupt $60 Billion Opiod Market With Cannabis Based Sustained Release Formulation Symbol: EMC  Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto. Canntab has developed a patent-pending oral sustained release formulation for cannabinoids
Complete Reading

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation    Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto. Canntab has developed a patent-pending oral sustained release formulation for cannabinoids
Complete Reading

Create Account



Log In Your Account



Dash_En